RE: Poorly written but I will take it.12 Sep 2022 09:33
Today
Sareum has submitted a Clinical Trial Authorisation (CTA) to the UK's Medicines and Healthcare Products Regulatory Agency to initiate a clinical trial of SDC-1801, with an initial focus on psoriasis, and hopes to begin dosing patients in 2023, subject to regulatory approvals."
28th July
Sareum has made significant progress advancing SDC-1801 towards clinical development and plans to initiate Phase 1 clinical trials in 2022,......
"planned" to start in 2022 but now "hope to begin in2023..
Bit of difference between "planning" and "hoping". Wonder who wrote it.